Interplay between key proteins could serve as a target for cancer treatment

Immunotherapy uses a person's own immune system to fight cancer. Immune checkpoint inhibitors are one class of immunotherapy that block specific proteins from slowing the immune response. As a result, immune cells become more active and can more effectively kill cancer cells. However, most patients either respond poorly to checkpoint inhibitors or eventually become resistant to the treatment.

👉 Full Story